Paolo Taddeucci Selected Research

Interleukin-4 (Interleukin 4)

1/2020

Efficacy of Dupilumab in two patients with severe and recalcitrant atopic dermatitis previously treated with extracorporeal photopheresis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Taddeucci Research Topics

Disease

2	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2022 - 01/2020
1	Pyoderma Gangrenosum 12/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Amenorrhea 01/2020
1	Pyogenic Granuloma 01/2020
1	Carcinoma (Carcinomatosis) 10/2019
1	Fibrosis (Cirrhosis) 01/2017
1	Melanoma (Melanoma, Malignant) 12/2015
1	Vitiligo 02/2005
1	Wounds and Injuries (Trauma) 12/2002
1	Infections 12/2002
1	Burns 12/2002
1	Pain (Aches) 12/2002

Drug/Important Bio-Agent (IBA)

3	HhAntag691IBA 01/2022 - 10/2019
1	Biological ProductsIBA 01/2020
1	Timolol (Blocadren)FDA LinkGeneric 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	dupilumabIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Interleukin-13IBA 01/2020
1	NucleotidesIBA 01/2017
1	Purinergic P2X7 ReceptorsIBA 01/2017
1	CollagenIBA 01/2017
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 12/2015
1	Proteins (Proteins, Gene)FDA Link 12/2002
1	Glycerol (Glycerine)FDA LinkGeneric 12/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 12/2002
1	Hip Replacement Arthroplasty (Total Hip Replacement) 12/2021
1	Photopheresis 01/2020